Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,344,339
+$2,562,575 QoQ
Shares Held
80,847
-1.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#599
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Haverford Trust Co holds $537,648,653 across 11 Drug Manufacturers - General names. ABBV ranks #4 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
996,670 | $253,124,279 | |
| 2 | LLY |
ELI LILLY & Co
|
165,960 | $199,057,419 | |
| 3 | MRK |
Merck & Co., Inc.
|
272,415 | $35,005,327 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
80,847 | $20,344,339 | |
| 5 | AMGN |
Amgen Inc
|
29,763 | $10,777,777 | |
| 6 | PFE |
Pfizer Inc
|
381,414 | $9,184,449 | |
| 7 | NVS |
Novartis AG
|
28,222 | $4,422,951 | |
| 8 | GSK |
GSK plc
|
47,770 | $2,504,103 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,344,339 | 80,847 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $17,781,764 | 81,759 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $18,917,601 | 82,794 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $19,317,613 | 83,431 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,654,132 | 95,109 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $20,010,207 | 95,505 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $16,997,893 | 95,655 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $18,821,621 | 95,309 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $16,306,749 | 95,072 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,927,016 | 98,446 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $14,713,316 | 94,943 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $13,691,161 | 91,850 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $12,594,829 | 93,482 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $14,800,054 | 92,866 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,757,578 | 91,316 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,216,867 | 91,028 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,754,362 | 96,333 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,170,958 | 99,753 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $13,488,548 | 99,620 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,682,258 | 99,029 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $10,564,280 | 93,788 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $11,001,428 | 101,658 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $10,731,929 | 100,158 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $8,058,805 | 92,006 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $8,523,103 | 86,811 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,299,236 | 82,678 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||